EBOS ceo Patrick Davies has forecast solid growth after a positive start to the financial year. Speaking at the company's annual general meeting yesterday, Davies said on the basis of the firm's current trading performance it expected underlying net profit after tax would grow by 7%-10%.
Also at the agm, chairman Mark Waller spoke about the current Pharmacy Review, with EBOS believing there are "some relatively minor changes to the funding model that could be implemented by the Australian Government to make the remuneration of wholesalers more relevant for the industry as we know it today".
The above article was sent to subscribers in Pharmacy Daily's issue from 20 Oct 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 20 Oct 16